| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8443069 | European Journal of Cancer | 2014 | 6 Pages |
Abstract
Usage of Oncotype DX assay is associated with several clinicopathological factors. These factors reflect the clinical uncertainty of benefit from chemotherapy in these subpopulations of patients and suggest how Oncotype DX assay could complement clinicopathological factors in helping clinicians on treatment selection.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Xiaofu Zhu, Susan Dent, Lise Paquet, Tinghua Zhang, Nadine Graham, Xinni Song,